Abstract

Background: Breast cancer in males is relatively uncommon, accounting for <1% of all breast cancers. Due to rarity of this disease; screening, diagnosis, and further management is a big challenge. Objectives: To analyze the role of fine needle aspiration cytology (FNAC) in the diagnosis of male breast lesion and to know the prevalence of male breast lesion and male breast cancer (MBC) with their clinicopathological characteristics in the Acharya Harihar Regional Cancer Centre, Cuttack, Odisha, India.
Materials and Methods: A retrospective study was conducted for a period of 7 years from January 2010 to December 2016 on male patients who presented with breast lump.
Results: A total 158 male patients were encountered out of which 27 (17.8%) were malignant and 131 (82.9%) were benign. Among malignant lesion, only invasive ductal carcinoma (IDC)-NOS types were encountered whereas in benign lesion, gynecomastia were predominant 115 (72.78%). Overall prevalence of male breast lesion was 2.5% whereas MBC was 1.34%. The mean age of the malignant cases was 56 years with age ranged between 32 and 82 years. In FNAC, there were no false positive cases in this series giving a specificity of 100%, sensitivity of 87 % and overall diagnostic accuracy of 94.93%. In histology, Stage III was maximum (14, 51.85%), followed by Stage IV (7, 25.92%) and Stage II (1, 2.7%). Conclusion: MBC is relatively lower than female breast cancer, but the incidence is still increasing with late presentation. FNAC is very reliable with high sensitivity and specificity for early and presumptive diagnosis.